PAPER
Cyclization of N-Arylthiobenzamides to Benzothiazoles
2585
6-Methoxy-2-phenyl-1,3-benzothiazole (3f)
Anal. Calcd for C21H14N2OS2: C, 67.35; H, 3.77; N, 7.48. Found: C,
67.01; H, 3.52; N, 7.30.
Cream crystals; yield: 77 mg (87%) from 1f (PhNO2, 22 h at reflux);
mp 114–116 °C (MeOH) (Lit.18 114–115 °C).
5,6-Dimethoxy-2-phenyl-1,3-benzothiazole (2m)
Cream crystals; yield: 63 mg (63%) from 1m (PhNO2, 24 h at re-
flux); 17.9 mg (18%) from 1m (1,2-dichlorobenzene); mp 144–
146 °C (MeOH) (Lit.3 145–146 °C).
5-Methoxy-2-phenyl-1,3-benzothiazole (3g)
Cream crystals; yield: 35.3 mg (40%) from 1g (PhNO2, 24 h at re-
flux); mp 76–77 °C (MeOH) (Lit.3 75–77 °C).
4,7-Dimethoxy-2-phenyl-1,3-benzothiazole (2g)
White needle-like crystals; yield: 12 mg (12%) from 1g (PhNO2);
mp 122–123 °C (MeOH) (Lit.6 122–124).
N-(3,4-Dimethoxyphenyl)benzamide (4m)
Brown solid; yield: 8 mg (9%) from 1m (PhNO2, 24 h at reflux);
17.0 mg (18%) from 1m (1,2-dichlorobenzene); mp 172–174 °C
(MeOH) (Lit.20 173–175 °C).
2-(4-Chlorophenyl)-5-methoxy-1,3-benzothiazole (3h)
Cream crystals; yield: 81 mg (90%) from 1h (PhNO2); mp 105–
107 °C (MeOH).
IR (ATR): 3004, 1593, 1465, 1026 cm–1.
1H NMR (200 MHz, CDCl3): δ = 3.95 (s, 3 H, OCH3), 7.04 (dd,
J = 6, 3 Hz, 1 H, H-6), 7.44 (d, J = 7 Hz, 2 H, H-3′,5′), 7.55 (d, J = 3
Hz, 1 H, H-4), 7.73 (d, J = 6 Hz, 1 H, H-7), 8.00 (d, J = 7 Hz, 2 H,
H-2′,6′.
2,6-Diphenyl[1,3]thiazolo[4,5-f][1,3]benzothiazole (17)
Yellow crystals; yield: 30 mg (44%) from 1n (PhNO2, 24 h at re-
flux); mp 260–262 °C (MeOH) (Lit.21 268–271 °C).
IR (ATR): 1509, 1480, 1305, 1239 cm–1.
1H NMR (200 MHz, CDCl3): δ = 7.53 (m, 6 H, H-3′,4′,5′ and H-
3′′,4′′,5′′), 8.13 (m, 4 H, H-2′,6′ and H-2′′,6′′), 8.55 (s, 1 H, H-4),
8.74 (s, 1 H, H-8).
13C NMR (50 MHz, CDCl3): δ = 55.6, 105.6, 115.7, 121.8, 126.9,
128.5, 129.2, 132.3, 136.9, 155.4, 159.3, 167.8.
13C NMR (50 MHz, CDCl3): δ = 112.4, 115.7, 126.5, 127.9, 130.1,
132.3, 147.0, 170.2.
Anal. Calcd for C14H10ClNOS: C, 60.98; H, 3.66; N, 5.08. Found:
C, 61.25; H, 3.40; N, 5.15.
2-Phenyl-1,3-benzothiazole (18)
Cream crystals; yield: 57 mg (67%) from 1o (PhNO2, 24 h at re-
flux); mp 109–110 °C (MeOH) (Lit.12 110–111 °C).
N-(5-Methoxy-2-phenyl-1,3-benzothiazol-6-yl)-4-methylben-
zenesulfonamide (3i)
Light-brown needles; yield: 90 mg (97%) from 1i (PhNO2, 18 h at
References
reflux); mp 171–173 °C (MeOH) (Lit.5 mp 184–186 °C).
(1) (a) Hari, N.; Tsukamoto, G.; Imamura, A.; Ohashi, M.;
Saito, T.; Yoshino, K. Chem. Pharm. Bull. 1992, 40, 2390.
(b) Henriksen, G.; Hauser, A. I.; Westwell, A. D.; Yousefi,
B. H.; Schwaiger, M.; Drzezga, A.; Wester, H.-J. J. Med.
Chem. 2007, 50, 1087. (c) Kok, S. H. L.; Gambari, R.; Chui,
C. H.; Yuen, M. C. W.; Lin, E.; Wong, R. S. M.; Lau, F. Y.;
Cheng, G. Y. M.; Lam, W. S.; Chan, S. H.; Lam, K. H.;
Cheng, C. H.; Lai, P. B. S.; Yu, M. W. Y.; Cheung, F.; Tang,
J. C. O.; Chan, A. S. C. Bioorg. Med. Chem. 2008, 16, 3626.
(d) Liu, C.; Lin, J.; Pitt, S.; Zhang, R. F.; Sack, J. S.; Kiefer,
S. E.; Kish, K.; Doweyko, A. M.; Zhang, H.; Marathe, P. H.;
Trzaskos, J.; Mckinnon, M.; Dodd, J. H.; Barrish, J. C.;
Schieven, G. L.; Leftheris, K. Bioorg. Med. Chem. Lett.
2008, 18, 1874. (e) Serdons, K.; Verduyckt, T.;
Vanderghinste, D.; Borghgraef, P.; Cleynhens, J.; Van
Leuven, F.; Kung, H.; Bormans, G.; Verbruggen, A. Eur. J.
Med. Chem. 2009, 44, 1415.
(2) For selected reviews on the synthesis of benzothiazole ring
systems, see: (a) Yadav, P. S.; Devprakash; Senthilkumar,
G. P. Int. J. Pharm. Sci. Drug Res. 2011, 3, 1. (b) Weekes,
A. A.; Westwell, A. D. Curr. Med. Chem. 2009, 16, 2430.
(c) Gupta, A.; Rawat, S. J. Curr. Pharm. Res. 2010, 3, 13.
(3) Downer, N. K.; Jackson, Y. A. Org. Biomol. Chem. 2004, 2,
3039.
6-Bromo-5-methoxy-2-phenyl-1,3-benzothiazole (3j)
White needles; yield: 75 mg (82%) from 1j (PhNO2, 22 h at reflux);
mp 157–159 °C (MeOH).
IR (ATR): 3069, 1592, 1454, 1037 cm–1.
1H NMR (200 MHz, CDCl3): δ = 4.00 (s, 3 H, OCH3), 7.51 (m, 3 H,
H-3′,4′,5′), 7.57 (s, 1 H, H-4), 8.01 (m, 3 H, H-7, 2′,6′).
13C NMR (50 MHz, CDCl3): δ = 56.5, 105.3, 110.5, 125.0, 127.4,
127.8, 129.1, 131.1, 133.4, 154.6, 155.2, 169.6.
Anal. Calcd for C14H10BrNOS: C, 52.51; H, 3.15; N, 4.37. Found:
C, 52.56; H, 3.02; N, 4.44.
N-(6-Methoxy-2-phenyl-1,3-benzothiazol-5-yl)benzamide (15)
Finely divided brown crystals; yield: 6 mg (7%) from 1e (PhNO2,
24 h at reflux); mp 184–186 °C (MeOH).
IR (ATR): 3429, 1660, 1572, 1057 cm–1.
1H NMR (200 MHz, CDCl3): δ = 4.01 (s, 3 H, OCH3), 7.35 (s, 1 H,
H-7), 7.51 (m, 6 H, H-3′,4′,5′ and H-3′′,4′′,5′′), 7.93 (m, 2 H, H-2′,6′)
8.06 (m, 2 H, H-2′′,6′′), 8.65 (s, 1 H, NH), 9.27 (s, 1 H, H-4).
13C NMR (50 MHz, CDCl3): δ = 56.4, 101.7, 114.0, 127.1, 127.3,
127.6, 128.8, 129.0, 130.5, 131.8, 133.8, 135.3, 138.1, 147.3, 148.8,
165.2, 166.2.
Anal. Calcd for C21H16N2O2S·0.5H2O: C, 68.27; H, 4.37; N, 7.58.
Found: C, 68.55; H, 4.46; N, 7.75.
(4) Barrett, O. V.; Downer-Riley, N. K.; Jackson, Y. A.
Heterocycles 2010, 81, 1641.
(5) Jackson, Y. A.; Lyon, M. A.; Townsend, N.; Bellabe, K.;
Soltanik, F. J. Chem. Soc., Perkin Trans. 1 2000, 205.
(6) Lyon, M. A.; Lawrence, S.; Williams, D. J.; Jackson, Y. A.
J. Chem. Soc., Perkin Trans. 1 1999, 437.
(7) Bunnett, J. F.; Hrutfiord, B. F. J. Am. Chem. Soc. 1961, 83,
1691.
(8) (a) Fields, E. K.; Meyerson, S. J. Org. Chem. 1972, 37,
3861. (b) Chon, J.; Paik, W. Bull. Korean Chem. Soc. 1983,
4, 55.
4-Methoxy-2,7-diphenyl[1,3]thiazolo[5,4-e][1,3]benzothiazole
(16)
Cream crystals; yield: 73 mg (79%) from 1e (PhNO2, 24 h at re-
flux); mp 239–241 °C (MeOH).
IR (ATR): 3429, 1660, 1572, 1057 cm–1 (Lit.19).
1H NMR (200 MHz, CDCl3): δ = 4.15 (s, 3 H, OCH3), 7.35 (s, 1 H,
H-5), 7.48 (m, 6 H, H-3′,4′,5′ and H-3′′,4′′,5′′), 8.10 (m, 2 H, H-
2′,6′), 8.18 (m, 2 H, H-2′′,6′′).
13C NMR (50 MHz, CDCl3): δ = 56.5, 99.2, 121.4, 127.2, 127.7,
129.0, 129.0, 130.7, 130.8, 131.4, 133.0, 133.5, 133.6, 144.7, 151.9,
166.7, 167.2.
(9) Buchwald, S. L.; Bolm, C. Angew. Chem. Int. Ed. 2009, 48,
5586.
(10) Larsson, P.-F.; Correa, A.; Carril, M.; Norrby, P.-O.; Bolm,
C. Angew. Chem. Int. Ed. 2009, 48, 5691.
© Georg Thieme Verlag Stuttgart · New York
Synthesis 2012, 44, 2579–2586